SEC ownership of IMMUCELL CORP /DE/

Top holders, 13D/G large-stake signals, insider positions, and transaction flow tied to CIK 0000811641.

Comparable stake leader

Ejnar A. Knudsen III

Disclosed value leader

Jonathan E. Rothschild

Comparable rows

1/42

Latest evidence

15 Apr 2026

Ownership snapshot CIK-linked ownership evidence from parsed SEC filings. 3 signals
Comparable ownership rows
1 of 42
Meaning: Rows with safely comparable ownership %
Latest 13D/G holder
Ejnar A. Knudsen III
Source: Latest parsed Schedule 13D/G stake
Latest parsed ownership date
15 Apr 2026
Freshness: Most recent filing date in this holder set
Issuer Names, identifiers, and filing context for this profile. 2 identity fields
Issuer CIK
0000811641
Issuer location
Portland, ME

Ownership snapshot

Top shareholders of IMMUCELL CORP /DE/ (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.

Comparable stake leader
Ejnar A. Knudsen III
Disclosed value leader
Jonathan E. Rothschild
Comparable rows
1/42
Latest evidence
15 Apr 2026
13D/G 3/4/5 13F Lead comparable stake: 9.2% 41 rows are not safely comparable across share classes. 13D/G row: Ejnar A. Knudsen III Showing 1-8 of 42 holder rows.

Quick read

Ejnar A. Knudsen III leads the comparable SEC ownership view at 9.2%.

1 of 42 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.

Open SEC evidence Opens Ejnar A. Knudsen III's linked filing trail.
Comparable ownership Top 1
Ejnar A. Knudsen III 9.2%

Ownership % is shown only when SEC disclosures are safely comparable across share classes.

Detailed SEC evidence table Showing 1-8 of 42 holder rows
Holder Evidence Ownership % Position 12M Net Δ As of
Ejnar A. Knudsen III
13D/G
9.2%
832,790 shares
$0 19 Nov 2025
Jonathan E. Rothschild
3/4/5
Director
class O/S missing
$4,302,205
514,003 shares
03 Jun 2021
VANGUARD CAPITAL MANAGEMENT LLC
13F
Company
13F
class O/S missing
$1,647,870
260,327 shares
31 Mar 2026
MORGAN STANLEY
13F
Company
13F
class O/S missing
$1,403,462
221,716 shares
31 Mar 2026
Joseph H. Crabb
3/4/5
Former VP and CSO
class O/S missing
$1,195,613
142,845 shares
09 Mar 2022
Michael F. Brigham
3/4/5
Director
mixed-class rows
$1,139,541
206,700 shares
mixed-class rows
20 Mar 2026
Boekhorst Paul Francis Olivier Te
3/4/5
President and CEO, Director
mixed-class rows
$970,146
119,238 shares
mixed-class rows
+$80,117 27 Jan 2026
RENAISSANCE TECHNOLOGIES LLC
13F
Company
13F
class O/S missing
$960,824
151,789 shares
31 Mar 2026
How to read this table

Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

Forms 3/4/5 flow

Insider trading overview

Net insider flow leans to buying over the last 12 months. Net value: +$95,671.

Buys
$95,671
Insiders: 2
Sells
$0
Insiders: 0
Net
+$95,671
Shares: +19,081
Window
Last 12 months
4 rolling buckets
Buy value Sell value
Shares: 19,081 Shares: 0
Window (months) Buy shares Sell shares Buy value Sell value Net value
0-3 0 0 $0 $0 $0
3-6 0 0 $0 $0 $0
6-9 19,081 0 $95,671 $0 +$95,671
9-12 0 0 $0 $0 $0

Reporting owners

Insider holders from Forms 3/4/5

Showing 1-16 of 16 reporting-owner rows connected to IMMUCELL CORP /DE/. Open a relationship link for the CIK-to-CIK filing trail.

Rows
16
Largest Forms 3/4/5 holder
Jonathan E. Rothschild
Net 12M change
+$95,671
Latest report
15 Apr 2026
Name Relationship Holdings Value Past Year Net Change Change % Valuation Report Date
Jonathan E. Rothschild Director $4,302,205 Mixed 03 Jun 2021
Joseph H. Crabb Former VP and CSO $1,195,613 Mixed 09 Mar 2022
Michael F. Brigham Director $1,139,541 Mixed 20 Mar 2026
Boekhorst Paul Francis Olivier Te President and CEO, Director $970,146 +$80,117 +9% Mixed 27 Jan 2026
David Scott Tomsche Director $625,795 +$15,554 +2.5% Mixed 15 Apr 2026
Timothy C. Fiori Chief Financial Officer, Director $164,700 Mixed 27 Jan 2026
Gloria F. Basse Director $52,979 Mixed 15 Apr 2026
Bryan K. Gathagan Director $42,320 Mixed 12 Jun 2025
Rosgen Steven T. Director $36,000 Mixed 16 Apr 2025
Paul R. Wainman Director $36,000 Mixed 15 Apr 2026
David Cunningham Director $36,000 Mixed 15 Dec 2022
Elizabeth Luttrell Williams VP of Manufacturing Operations $8,150 Mixed 31 Jan 2022
Kathy Turner V Director Mixed 15 Apr 2026
Bobbi Jo Brockmann VP of Sales and Marketing, Director Mixed 27 Jan 2026
Gilles Guillemette Director Mixed 15 Apr 2026
Anthony DiMarco Director Mixed 15 Apr 2026

Recent insider transactions for IMMUCELL CORP /DE/

Showing up to 300 recent insider transactions from the last 12 months.

Insider Symbol Class Transaction % SEC-reported value SEC-reported price Shares Shares owned Date Ownership
Kathy Turner V ICCC Non Qualified Stock Options (Right to buy) Award 17,899 17,899 15 Apr 2026 Direct
David Scott Tomsche ICCC Non Qualified Stock Options (Right to buy) Award 11,933 11,933 15 Apr 2026 Direct
Gloria F. Basse ICCC Non Qualified Stock Options (Right to buy) Award 11,933 11,933 15 Apr 2026 Direct
Paul R. Wainman ICCC Non Qualified Stock Options (Right to buy) Award 11,933 11,933 15 Apr 2026 Direct
Michael F. Brigham ICCC Common Stock, par value $.01 per share Tax liability -10.5% -24,052 205,700 20 Mar 2026 Direct
Michael F. Brigham ICCC Common Stock, par value $.01 per share Options Exercise 12.2% 25,000 229,752 20 Mar 2026 Direct
Michael F. Brigham ICCC Stock Options (right to buy) Options Exercise -100% -25,000 0 20 Mar 2026 Direct
Boekhorst Paul Francis Olivier Te ICCC Stock Options (right to buy) Award 109,500 109,500 27 Jan 2026 Direct
Timothy C. Fiori ICCC Stock Options (right to buy) Award 120,000 120,000 27 Jan 2026 Direct
Bobbi Jo Brockmann ICCC Stock Options (right to buy) Award 100,000 100,000 27 Jan 2026 Direct
Boekhorst Paul Francis Olivier Te ICCC Common Stock $0.10 par value per share Purchase 33.3% $13,376 $5.50 2,432 9,738 04 Dec 2025 Direct
Boekhorst Paul Francis Olivier Te ICCC Common Stock $0.10 par value per share Purchase 97% $18,152 $5.04 3,598 7,306 03 Dec 2025 Direct
Boekhorst Paul Francis Olivier Te ICCC Common Stock $0.10 par value per share Purchase 163.9% $30,536 $5.02 6,077 9,785 03 Dec 2025 Direct
Boekhorst Paul Francis Olivier Te ICCC Common Stock $0.10 par value per share Purchase $18,053 $4.87 3,708 3,708 02 Dec 2025 Direct
David Scott Tomsche ICCC Common Stock $0.10 par value per share Purchase 52.6% $7,781 $4.76 1,633 4,740 25 Nov 2025 By Spouse
David Scott Tomsche ICCC Common Stock $0.10 par value per share Purchase 3.2% $7,773 $4.76 1,633 52,720 25 Nov 2025 Direct
Boekhorst Paul Francis Olivier Te ICCC Stock Options (right to buy) Award 97.8% 74,277 150,260 07 Nov 2025 Direct
* marks a reported price that did not pass the local price check.
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .